A circulating anticoagulant against factor V.
D000368:Aged; D000925:Anticoagulants / Q000378:metabolism*; D001779:Blood Coagulation Factors / Q000378:metabolism; D002512:Cephalothin / Q000009:adverse effects* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005165:Factor V / Q000378:metabolism*; D005166:Factor V Deficiency / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D008297:Male; D011183:Postoperative Complications; D011468:Prostatectomy; D012772:Shock, Septic / Q000188:drug therapy / Q000209:etiology; D013997:Time Factors
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D007074:Immunoglobulin G; D003520:Cyclophosphamide; D005165:Factor V; D002512:Cephalothin